Depomed isn’t anti-takeover, CEO says. It was just anti-Horizon

Carly Helfand

SAN FRANCISCO–Let be clear: it may not have been too keen on Horizon Pharma's buyout offer from last year, but that doesn't mean it's opposed to a takeover.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS